2006
Clinical Features and Prognostic Assessment of Nodal Marginal Zone B-Cell Lymphoma, a Rare Disease with Follicular-Like Behaviour.
Arcaini L, Paulli M, Burcheri S, Boveri E, Rossi A, Spina M, Passamonti F, Montanari M, Gallamini A, Uziel L, Crugnola M, Montanari F, Pascutto C, Morra E, Lazzarino M. Clinical Features and Prognostic Assessment of Nodal Marginal Zone B-Cell Lymphoma, a Rare Disease with Follicular-Like Behaviour. Blood 2006, 108: 2427. DOI: 10.1182/blood.v108.11.2427.2427.Peer-Reviewed Original ResearchMarginal zone B-cell lymphomaPrimary nodal marginal zone B-cell lymphomaNodal marginal zone B-cell lymphomaEvent-free survivalB-cell lymphomaShorter event-free survivalPrimary nodal marginal zone lymphomaFLIPI scoreMarginal zone lymphomaNodal marginal zone lymphomaClinical featuresB symptomsHCV serologyOverall survivalBorderline significancePrognostic assessmentLower riskRare diseaseMedian age 63 yearsPeripheral blood involvementAge 63 yearsPositive HCV serologyWorse overall survivalOverall response rateLymph node localization
2005
Correlation of the FLIPI score for follicular lymphoma with period of diagnosis and type of treatment
Arcaini L, Colombo N, Passamonti F, Burcheri S, Orlandi E, Brusamolino E, Della Porta M, Rumi E, Montanari F, Pascutto C, Paulli M, Lazzarino M. Correlation of the FLIPI score for follicular lymphoma with period of diagnosis and type of treatment. Leukemia Research 2005, 30: 277-282. PMID: 16112730, DOI: 10.1016/j.leukres.2005.07.006.Peer-Reviewed Original ResearchConceptsFLIPI scorePeriod of diagnosisHigh-risk groupFollicular lymphomaIntermediate riskLower riskRisk groupsMedian OSIPI scorePrognostic categoriesPoor-risk groupSubset of patientsSurvival of patientsTime of diagnosisFollicular lymphoma patientsUse of anthracyclinesDistribution of patientsType of treatmentIndependent seriesIndolent outcomeClinical characteristicsIndolent disorderPrognostic scorePrognostic indexWorse prognosis